Dimethyl amino azetidine amides as JAK inhibitors
US12398135B2 · kind B2 · utility
0Cited by
24References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2024 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | May 31, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides compounds of formula (I): where the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are useful as JAK kinase inhibitors. The invention also provides pharmaceutical compositions comprising such compounds and methods of using such compounds to treat respiratory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.